Company attributes
Industry
Location
B2X
CEO
Founder
Pitchbook URL
Legal Name
Elixirgen Therapeutics, LLC
Legal classification
Date Incorporated
May 16, 2018
Number of Employees (Ranges)
1 – 10
Email Address
Phone Number
Full Address
855 North Wolfe Street Suite 624 Baltimore, MD 21205 United States0
CIK Number
Place of Incorporation
Investors
Founded Date
2017
Total Funding Amount (USD)
18,906,900
13,900,000
28,406,869
Latest Funding Round Date
2021
Also Known As
ELIXIRGEN THERAPEUTICS, INC.
Latest Funding Type
Patents Assigned (Count)
3
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
5,499,971
4,200,000
Elixirgen Therapeutics, Inc. is a biotechnology company that researches, develops, and distributes drugs and medical devices, vaccines, against genetic diseases. The company was founded in 2017 by Akihiro Ko and Minoru Ko.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
